Ho SK - Search Results

1

Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.

Poon TC, Chan AT, Zee B, Ho SK, Mok TS, Leung TW, Johnson PJ. Poon TC, et al. Among authors: ho sk. Oncology. 2001;61(4):275-83. doi: 10.1159/000055334. Oncology. 2001. PMID: 11721174

2

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour.

Johnson PJ, Poon TC, Hjelm NM, Ho CS, Ho SK, Welby C, Stevenson D, Patel T, Parekh R, Townsend RR. Johnson PJ, et al. Among authors: ho cs, ho sk. Br J Cancer. 1999 Dec;81(7):1188-95. doi: 10.1038/sj.bjc.6690828. Br J Cancer. 1999. PMID: 10584881 Free PMC article.

3

Structures of disease-specific serum alpha-fetoprotein isoforms.

Johnson PJ, Poon TC, Hjelm NM, Ho CS, Blake C, Ho SK. Johnson PJ, et al. Among authors: ho cs, ho sk. Br J Cancer. 2000 Nov;83(10):1330-7. doi: 10.1054/bjoc.2000.1441. Br J Cancer. 2000. PMID: 11044358 Free PMC article.

4

Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors.

Leung TW, Lau WY, Ho SK, Ward SC, Chow JH, Chan MS, Metreweli C, Johnson PJ, Li AK. Leung TW, et al. Among authors: ho sk. Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):919-24. doi: 10.1016/0360-3016(95)00039-3. Int J Radiat Oncol Biol Phys. 1995. PMID: 7591903

5

Determination of tumour vascularity using selective hepatic angiography as compared with intrahepatic-arterial technetium-99m macroaggregated albumin scan in hepatocellular carcinoma.

Leung TW, Lau WY, Ho SK, Chan M, Leung NW, Lin J, Metreweli C, Johnson PJ, Li AK. Leung TW, et al. Among authors: ho sk. Cancer Chemother Pharmacol. 1994;33 Suppl:S33-6. doi: 10.1007/BF00686665. Cancer Chemother Pharmacol. 1994. PMID: 8137482

6

Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.

Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, Mok TS, Yeo W, Liew CT, Leung NW, Tang AM, Johnson PJ. Leung TW, et al. Among authors: ho sk. Clin Cancer Res. 1999 Jul;5(7):1676-81. Clin Cancer Res. 1999. PMID: 10430068 Clinical Trial.

7

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.

Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ. Lau WY, et al. Among authors: ho sk. Lancet. 1999 Mar 6;353(9155):797-801. doi: 10.1016/s0140-6736(98)06475-7. Lancet. 1999. PMID: 10459961 Clinical Trial.

8

Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma.

Lau WY, Leung TW, Lai BS, Liew CT, Ho SK, Yu SC, Tang AM. Lau WY, et al. Among authors: ho sk. Ann Surg. 2001 Feb;233(2):236-41. doi: 10.1097/00000658-200102000-00013. Ann Surg. 2001. PMID: 11176130 Free PMC article.

9

Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin.

Leung WT, Lau WY, Ho SK, Chan M, Leung NW, Lin J, Metreweli C, Johnson PJ, Li AK. Leung WT, et al. Among authors: ho sk. J Nucl Med. 1994 Jan;35(1):70-3. J Nucl Med. 1994. PMID: 8271063 Free article.

10

Yuehchukene, a bis-indole alkaloid, and cyclophosphamide are active in breast cancer in vitro.

Leung TW, Cheng G, Chui CH, Ho SK, Lau FY, Tjong JK, Poon TC, Tang JC, Tse WC, Cheng KF, Kong YC. Leung TW, et al. Among authors: ho sk. Chemotherapy. 2000 Jan-Feb;46(1):62-8. doi: 10.1159/000007257. Chemotherapy. 2000. PMID: 10601799

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters